In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Orion Corporation

https://www.orion.fi/en/

Latest From Orion Corporation

Deal Watch: NewAmsterdam To Take On Amgen’s Stalled CETP Inhibitor

New company licenses obicetrapib from Amgen after previous companies’ setbacks in CETP class and works with FDA on a Phase III protocol. BMS buys protein-engineering specialist Forbius.

Deals Business Strategies

ASCO 2020: Can Xtandi PROSPER In Prostate OS Data Battle?

While Xtandi has positive new survival data in prostate cancer, other rivals in the competitive market are reporting the same at ASCO.

ASCO Clinical Trials

Tech Transfer Roundup: Inside The Law That Transformed The Research Landscape

The Bayh-Dole act of 1980 facilitated deal-making between private-sector firms and research institutions, largely seeding the US biotech industry. Plus, an overview of the latest tech transfer deals.

Deals Business Strategies

New Drug Launches Worldwide Dipped In 2019

The number of new active substances launched in their first market in 2019 dropped as 2018’s superlative performance gave way to something more usual.

Companies Innovation
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Vaccines
    • Drug Delivery
      • Pulmonary
  • Other Names / Subsidiaries
    • Orion Corporation
    • Orion Diagnostica Oy
    • Orion Pharma
    • Orion Oyj
UsernamePublicRestriction

Register